Story

Elevance Health Stock Jumps After Reaffirming Guidance, Signaling Strong Q3

ENTHMSVIIDZHZH-TWJAKOHI
Sep 10, 20261 min read
Elevance Health Stock Jumps After Reaffirming Guidance, Signaling Strong Q3
Text size
Background

Shares of Elevance Health (ELV) surged 5.8% to $418.21 in mid-day trading after the health insurer reaffirmed its full-year earnings guidance and provided a positive update on its third-quarter performance.

The company's strong intra-quarter update stood in stark contrast to the broader market, with the S&P 500, Dow Jones, and Nasdaq all trading lower for the day, indicating the rally was driven by company-specific news.

Upbeat Financial Outlook

In a Regulation FD disclosure filed via a Form 8-K, Elevance Health reaffirmed its full-year 2026 adjusted earnings guidance of at least $27.00 per diluted share. The company also maintained its operating cash flow target for 2026 of at least $6 billion.

Speaking at the Wells Fargo 21st Annual Healthcare Conference, management signaled that third-quarter adjusted EPS is tracking ahead of the outlook provided following its second-quarter results. The company attributed the strong performance to favorable benefit expense trends, a key metric for investors monitoring medical costs in the health insurance sector.

Sample IUX Markets – In-articleAd

Long-Term Growth and Market Context

Elevance also reiterated its long-term ambition to deliver at least 12% adjusted EPS growth in 2027, based on its 2026 results. This commitment to sustained growth helped reinforce investor confidence in the company's financial trajectory.

The positive update was particularly well-received amid persistent industry-wide concerns over medical cost inflation and pressures related to Medicaid member redeterminations. Today also marked the ex-dividend date for the company's $1.72 per share quarterly dividend, payable on September 25, which may have provided a minor additional catalyst for buying interest.

Read next

More on Stocks
Back to latest news

LATEST